Medicines Co (MDCO) Reports Q2 Adj-EPS of 46c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts MDCO Hot Sheet
Price: $84.90 --0%
Financial Fact:
Other income (expense): 865K
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Other income (expense): 865K
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Medicines Co (NASDAQ: MDCO) reported Q2 adj-EPS of $0.46, GAAP EPS were $0.25, vs. the analyst estimate of $0.17. Revenue for the quarter came in at $135.7 million versus the consensus estimate of $131.78 million.
For earnings history and earnings-related data on Medicines Co (MDCO) click here.
For earnings history and earnings-related data on Medicines Co (MDCO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Walmart stock climbs on AI shopping tool expansion
- Vistra stock sinks ahead of earnings report
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
